BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11157661)

  • 1. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling.
    Feron O; Kelly RA
    Circ Res; 2001 Feb; 88(2):129-31. PubMed ID: 11157661
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
    Sowa G; Pypaert M; Sessa WC
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation.
    Feron O; Han X; Kelly RA
    Life Sci; 1999; 64(6-7):471-7. PubMed ID: 10069512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae.
    Chambliss KL; Yuhanna IS; Mineo C; Liu P; German Z; Sherman TS; Mendelsohn ME; Anderson RG; Shaul PW
    Circ Res; 2000 Nov; 87(11):E44-52. PubMed ID: 11090554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold.
    Li H; Brodsky S; Basco M; Romanov V; De Angelis DA; Goligorsky MS
    Circ Res; 2001 Feb; 88(2):229-36. PubMed ID: 11157677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
    Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
    J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolae: a once-elusive structure gets some respect.
    Marx J
    Science; 2001 Nov; 294(5548):1862-5. PubMed ID: 11729300
    [No Abstract]   [Full Text] [Related]  

  • 9. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.
    Feron O; Zhao YY; Kelly RA
    Ann N Y Acad Sci; 1999 Jun; 874():11-9. PubMed ID: 10415516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of regulatory mechanisms for eNOS: an emerging role for the cytoskeleton.
    Skidgel RA
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1179-82. PubMed ID: 12003771
    [No Abstract]   [Full Text] [Related]  

  • 13. Signal transduction of eNOS activation.
    Fleming I; Busse R
    Cardiovasc Res; 1999 Aug; 43(3):532-41. PubMed ID: 10690325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
    Dessy C; Kelly RA; Balligand JL; Feron O
    EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular regulation of endothelial nitric oxide synthase.
    Govers R; Rabelink TJ
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F193-206. PubMed ID: 11208594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide, caveolae, and vascular pathology.
    Li XA; Everson W; Smart EJ
    Cardiovasc Toxicol; 2006; 6(1):1-13. PubMed ID: 16845178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything.
    Goligorsky MS; Li H; Brodsky S; Chen J
    Am J Physiol Renal Physiol; 2002 Jul; 283(1):F1-10. PubMed ID: 12060581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein induces eNOS translocation to membrane caveolae: the role of RhoA activation and stress fiber formation.
    Zhu Y; Liao HL; Niu XL; Yuan Y; Lin T; Verna L; Stemerman MB
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):117-26. PubMed ID: 14729074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
    Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
    Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.